Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Plos One|May 9, 2020
A survey-wide association study to identify youth-specific correlates of major depressive episodesRahul Madhav Dhodapkar
Seminars in Hematology|November 27, 2024
Smoldering multiple myeloma: Integrating biology and risk into managementRoshani Patel, Elizabeth Hill, Madhav Dhodapkar
Cancer Biology & Therapy|July 5, 2011
Vesicle transfer and cell fusion: Emerging concepts of cell-cell communication in the tumor microenvironmentT Kevin Howcroft, Huang-Ge Zhang, Madhav Dhodapkar, et al.
Molecular Genetics and Metabolism|February 12, 2020
Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathyShiny Nair, Noffar Bar, Mina L Xu, et al.
Blood|August 19, 2007
Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursorsSayuri Yamazaki, Anthony J Bonito, Radek Spisek, et al.
Journal of Clinical Immunology|June 28, 2005
Spontaneous proliferation and type 2 cytokine secretion by CD4+T cells in patients with metastatic melanoma vaccinated with antigen-pulsed dendritic cellsA Karolina Palucka, John Connolly, Hideki Ueno, et al.
The Journal of Biological Chemistry|August 8, 2018
The contribution of cross-talk between the cell-surface proteins CD36 and CD47-TSP-1 in osteoclast formation and functionSrinivas V Koduru, Ben-Hua Sun, Joanne M Walker, et al.
Cancer Immunology, Immunotherapy : CII|December 7, 2005
Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cellsJoseph W Fay, A Karolina Palucka, Sophie Paczesny, et al.
The Journal of Experimental Medicine|January 7, 2004
Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgarisEdmund Lee, William L Trepicchio, Judith L Oestreicher, et al.
Clinical Lung Cancer|July 21, 2022
A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non-Small-Cell Lung Cancer (NSCLC) who Progressed on Platinum-Doublet and PD-1/PD-L1 BlockadeBadi El Osta, Jennifer Carlisle, Conor Steuer, et al.
Pageof 4